{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:45:51Z","timestamp":1792111551880,"version":"4.4.0"},"reference-count":26,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Adults with type 1 diabetes (T1D) experience substantial inpatient morbidity, including frequent readmissions and measurable in-hospital mortality, contributing significantly to US health care utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the association between insulin delivery modality and 30-day readmission and in-hospital mortality among adults hospitalized with T1D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, and participants<\/jats:title>\n                    <jats:p>Retrospective cohort study using the 2022 Nationwide Readmissions Database, a nationally representative all-payer inpatient database. Adults (\u226518 years) hospitalized with T1D were identified using ICD-10-CM codes. Index admissions were defined as the first eligible hospitalization per patient within the calendar year; December and elective admissions were excluded to ensure complete 30-day follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Insulin pump therapy (\u00b1 injectable insulin) vs injectable insulin only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcomes and measures<\/jats:title>\n                    <jats:p>Primary outcome was time to first all-cause readmission within 30 days. Secondary outcomes included in-hospital mortality during index admission and readmission. Survey-weighted Cox and logistic regression models estimated adjusted hazard ratios (aHRs) and odds ratios (aORs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The weighted cohort included 230 958 adult index admissions. Thirty-day readmission occurred in 14.64% of pump users vs 20.63% of injectable-only users. After multivariable adjustment, pump therapy was associated with lower readmission risk (aHR, 0.77; 95% CI, 0.74-0.81; P &amp;lt; .001). In secondary analyses, this association persisted for 90-day readmission outcomes. In-hospital mortality during index admission was lower among pump users (0.90% [95% CI, 0.78-1.05]) compared with injectable-only users (1.31% [95% CI, 1.21-1.42]). Pump therapy remained associated with reduced mortality (aOR, 0.78; 95% CI, 0.66-0.93; P = .006).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this nationally representative cohort, insulin pump therapy was independently associated with lower 30-day readmission and in-hospital mortality among adults with T1D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag307","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:11:00Z","timestamp":1785323460000},"page":"3269-3276","source":"Crossref","is-referenced-by-count":1,"title":["Insulin pump use and hospital outcomes in adults with type 1 diabetes: a 2022 Nationwide Readmissions Database analysis"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5453-0082","authenticated-orcid":false,"given":"Reshma","family":"Reguram","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Wayne State University and Trinity Health Oakland Hospital , Pontiac, MI 48341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushi","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University and Trinity Health Oakland Hospital , Pontiac, MI 48341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanisha","family":"Vora","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University and Trinity Health Oakland Hospital , Pontiac, MI 48341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Arsene","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University and Trinity Health Oakland Hospital , Pontiac, MI 48341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Krishnamoorthy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University and Trinity Health Oakland Hospital , Pontiac, MI 48341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhanva","family":"Neti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Wayne State University School of Medicine , Detroit, MI 48203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga","family":"Yerasuri","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Trinity Health Livonia , Livonia, MI 48152, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F N U","family":"Manas","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Trinity Health Endocrinology , Rochester Hills, MI 48309, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-075X","authenticated-orcid":false,"given":"Wael","family":"Taha","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Wayne State University , Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"1","key":"2026101520054975000_dgag307-B1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"issue":"3","key":"2026101520054975000_dgag307-B2","first-page":"311","article-title":"Estimation of annual health care costs for adults with type 1 diabetes in the United States","volume":"26","author":"Joish","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"2026101520054975000_dgag307-B3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002633","article-title":"Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis","volume":"10","author":"Jiao","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"2026101520054975000_dgag307-B4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2019.0417","article-title":"The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis","volume":"22","author":"Pease","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2026101520054975000_dgag307-B5","doi-asserted-by":"crossref","DOI":"10.3390\/life13081663","article-title":"Current technologies for managing type 1 diabetes mellitus and their impact on quality of life\u2014a narrative review","volume":"13","author":"Elian","year":"2023","journal-title":"Life"},{"issue":"3","key":"2026101520054975000_dgag307-B6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/17423953211023962","article-title":"Values and control in type 1 diabetes beyond glycemic outcomes: a qualitative interview study of everyday life with an insulin pump","volume":"18","author":"Cleal","year":"2022","journal-title":"Chronic Illn"},{"key":"2026101520054975000_dgag307-B7"},{"key":"2026101520054975000_dgag307-B8"},{"key":"2026101520054975000_dgag307-B9"},{"issue":"1","key":"2026101520054975000_dgag307-B10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson Comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"key":"2026101520054975000_dgag307-B11"},{"key":"2026101520054975000_dgag307-B12","doi-asserted-by":"crossref","unstructured":"Reguram R, Shah R, Vora T, et al \u00a0Supplementary Material for insulin delivery modality and inpatient outcomes in adults with type 1 diabetes mellitus: Evidence from the 2022 Nationwide Readmissions Database. Zenodo; 2026.","DOI":"10.1210\/clinem\/dgag307"},{"issue":"1","key":"2026101520054975000_dgag307-B13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2337\/dc22-1055","article-title":"Racial disparities in access and use of diabetes technology among adult patients with type 1 diabetes in a U.S. academic medical center","volume":"46","author":"Kanbour","year":"2023","journal-title":"Diabetes Care"},{"issue":"10","key":"2026101520054975000_dgag307-B14","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1111\/dom.15774","article-title":"Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: key themes and evidentiary gaps","volume":"26","author":"Patel","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"S2","key":"2026101520054975000_dgag307-B15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/dom.15087","article-title":"Use of insulin pumps and closed-loop systems among people living with diabetes: a narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers","volume":"25","author":"Jendle","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2026101520054975000_dgag307-B16","doi-asserted-by":"crossref","first-page":"13165","DOI":"10.1038\/s41598-023-40423-y","article-title":"Efficacy and safety of closed-loop control system for type one diabetes in adolescents: a meta analysis","volume":"13","author":"Jabari","year":"2023","journal-title":"Sci Rep"},{"issue":"9","key":"2026101520054975000_dgag307-B17","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/clinem\/dgab372","article-title":"Rate and predictors of 30-day readmission following diabetic ketoacidosis in type 1 diabetes mellitus: a US analysis","volume":"106","author":"Shaka","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026101520054975000_dgag307-B18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40842-016-0040-x","article-title":"The relationship between diabetes mellitus and 30-day readmission rates","volume":"3","author":"Ostling","year":"2017","journal-title":"Clin Diabetes Endocrinol"},{"issue":"2","key":"2026101520054975000_dgag307-B19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-021-01375-7","article-title":"Managing patients with insulin pumps and continuous glucose monitors in the hospital: to wear or not to wear","volume":"21","author":"Yeh","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"3","key":"2026101520054975000_dgag307-B20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1573399816666200130093523","article-title":"Association between intra-hospital uncontrolled glycemia and health outcomes in patients with diabetes: a systematic review of observational studies","volume":"17","author":"Carvalho","year":"2021","journal-title":"Curr Diabetes Rev"},{"issue":"8","key":"2026101520054975000_dgag307-B21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2337\/dci18-0002","article-title":"Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital","volume":"41","author":"Umpierrez","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"2026101520054975000_dgag307-B22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/dsi22-0011","article-title":"Supporting the use of a person's own diabetes technology in the inpatient setting","volume":"35","author":"Pattison","year":"2022","journal-title":"Diabetes Spectr Publ Am Diabetes Assoc"},{"key":"2026101520054975000_dgag307-B23"},{"issue":"10","key":"2026101520054975000_dgag307-B24","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1111\/dom.15799","article-title":"Persistent disparities in insulin pump uptake despite a universal pump programme for type 1 diabetes in Ontario, Canada","volume":"26","author":"Soliman","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"2026101520054975000_dgag307-B25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/193229681200600502","article-title":"Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years\u2019 experience with 253 cases","volume":"6","author":"Cook","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2026101520054975000_dgag307-B26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/193229681000400415","article-title":"Outpatient-to-inpatient transition of insulin pump therapy: successes and continuing challenges","volume":"4","author":"Nassar","year":"2010","journal-title":"J Diabetes Sci Technol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag307\/70386257\/dgag307.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/3269\/70386257\/dgag307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/3269\/70386257\/dgag307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:05:55Z","timestamp":1792109155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/11\/3269\/8747348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,7,30]]},"published-print":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag307","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,7,30]]}}}